JBM  Vol.6 No.3 , March 2018
Fusobacterium nucleatum—The Cause of Human Colorectal Cancer
Abstract: Objective: Accumulating evidence indicates that the gut microbiome has an increasingly important role in human disease and health. Fusobacterium nucleatum has been identified in several studies as the leading gut bacterium which is present in colorectal cancer (CRC). Still it is not clear if Fusobacterium plays a causal role. Methods: To explore the cause-effect relationship between Fusobacterium nucleatum and colorectal cancer, a systematic review and re-analysis of studies published were performed. The method of the conditio sine qua non relationship was used to proof the hypothesis without Fusobacterium nucleatum infection, no colorectal cancer. The mathematical formula of the causal relationship k was used to proof the hypothesis, whether there is a cause-effect relationship between Fusobacterium nucleatum and colorectal cancer. Significance was indicated by a p-value of less than 0.05. Result: The data analyzed support the Null-hypothesis that without Fusobacterium nucleatum infection, no colorectal cancer. In the same respect, the studies analyzed provide highly significant cause-effect relationship between Fusobacterium nucleatum and colorectal cancer. Conclusion: The findings of this study suggest that Fusobacterium (nucleatum) is the cause of colorectal cancer.
Cite this paper: Barukčić, I. (2018) Fusobacterium nucleatum—The Cause of Human Colorectal Cancer. Journal of Biosciences and Medicines, 6, 31-69. doi: 10.4236/jbm.2018.63004.

[1]   Ferlay, J., Soerjomataram, I., Ervik, M., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D.M., Forman, D. and Bray, F. (2013) GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 11: Lyon. International Agency for Research on Cancer.

[2]   Jemal, A., Bray, F., Center, M.M., Ferlay, J., Ward, E. and Forman, D. (2011) Global Cancer Statistics. CA: A Cancer Journal for Clinicians, 61, 69-90.

[3]   Riboli, E. and Norat, T. (2003) Epidemiologic Evidence of the Protective Effect of Fruit and Vegetables on Cancerrisk. The American Journal of Clinical Nutrition, 78, 559S-569S.

[4]   Liang, P.S., Chen, T.Y. and Giovannucci, E. (2009) Cigarette Smoking and Colorectal Cancer Incidence and Mortality: Systematic Review and Meta-Analysis. International Journal of Cancer, 124, 2406-2415.

[5]   Taylor, D.P., Burt, R.W., Williams, M.S., Haug, P.J. and Cannon-Albright, L.A. (2010) Population Based Family History-Specific Risks for Colorectal Cancer: A Constellation Approach. Gastroenterology, 138, 877-885.

[6]   Chan, D.S., Lau, R., Aune, D., Vieira, R., Greenwood, D.C., Kampman, E. and Norat, T. (2011) Red and Processed Meat and Colorectal Cancer Incidence: Meta-Analysis of Prospective Studies. PLoS ONE, 6, e20456.

[7]   Fedirko, V., Tramacere, I., Bagnardi, V., Rota, M., Scotti, L., Islami, F., Negri, E., Straif, K., Romieu, I., La Vecchia, C., Boffetta, P. and Jenab, M. (2011) Alcoholdrinking and Colorectal Cancer Risk: An Overall and Dose-Response Metaanalysis of Published Studies. Annals of Oncology, 22, 1958-1972.

[8]   Jiang, Y., Ben, Q., Shen, H., Lu, W., Zhang, Y. and Zhu, J. (2011) Diabetes Mellitus and Incidence and Mortality of Colorectal Cancer: A Systematic Review and Metaanalysis of Cohort Studies. European Journal of Epidemiology, 26, 863-876.

[9]   Jess, T., Rungoe, C. and Peyrin-Biroulet, L. (2012) Risk of Colorectal Cancer in Patients with Ulcerative Colitis: A Meta-Analysis of Population-Based Cohort Studies. Clinical Gastroenterology and Hepatology, 10, 639-645.

[10]   Ma, Y., Yang, Y., Wang, F., Zhang, P., Shi, C., Zou, Y., et al. (2013) Obesity and Risk of Colorectal Cancer: A Systematic Review of Prospective Studies. PLoS ONE, 8, e53916.

[11]   Brenner, H., Kloor, M. and Pox, C.P. (2014) Colorectal Cancer. Lancet, 383, 1490-1502.

[12]   De Flora, S. and La Maestra, S. (2015) Epidemiology of Cancers of Infectious Origin and Prevention Strategies. Journal of Preventive Medicine and Hygiene, 56, E15-E20.

[13]   Chen, H., Chen, X.Z., Waterboer, T., Castro, F.A. and Brenner, H. (2015) Viral Infections and Colorectal Cancer: A Systematic Review of Epidemiological Studies. Int J Cancer, 137, 12-24.

[14]   Schwabe, R.F. and Jobin, C. (2013) The Microbiome and Cancer. Nature Reviews Cancer, 13, 800-812.

[15]   Dickson, R.P., Martinez, F.J. and Huffnagle, G.B. (2014) The Role of the Microbiome in Exacerbations of Chronic Lung Diseases. Lancet, 384, 691-702.

[16]   Kahn, S.E., Cooper, M.E. and Del Prato, S. (2014) Pathophysiology and Treatment of Type 2 Diabetes: Perspectives on the Past, Present, and Future. Lancet, 383, 1068-1083.

[17]   Rowland, I.R. (2009) The Role of the Gastrointestinal Microbiota in Colorectal Cancer. Current Pharmaceutical Design, 15, 1524-1527.

[18]   Warren, R.L., Freeman, D.J., Pleasance, S., Watson, P., Moore, R.A., Cochrane, K., Allen-Vercoe, E. and Holt, R.A. (2013) Co-Occurrence of Anaerobic Bacteria in Colorectal Carcinomas. Microbiome, 1, 16.

[19]   Wu, Q., Yang, Z.P., Xu, P., Gao, L.C. and Fan, D.M. (2016) Association between Helicobacter pylori Infection and the Risk of Colorectal Neoplasia: A Systematic Review and Meta-Analysis. Colorectal Dis., 15, e352-e364.

[20]   Castellarin, M., Warren, R.L., Freeman, J.D., Dreolini, L., Krzywinski, M., Strauss, J., et al. (2012) Fusobacterium nucleatum Infection Is Prevalent in Human Colorectal Carcinoma. Genome Research, 22, 299-306.

[21]   Kostic, A.D., Gevers, D., Pedamallu, C.S., Michaud, M., Duke, F., Earl, A.M., et al. (2012) Genomic Analysis Identifies Association of Fusobacterium with Colorectal Carcinoma. Genome Research, 22, 292-298.

[22]   Kostic, A.D., Chun, E., Robertson, L., Glickman, J.N., Gallini, C.A., Michaud, M., Clancy, T.E., Chung, D.C., Lochhead, P., Hold, G.L., El-Omar, E.M., Brenner, D., Fuchs, C.S., Meyerson, M. and Garrett, W.S. (2013) Fusobacterium nucleatum Potentiates Intestinal Tumorigenesis and Modulates the Tumor-Immune Microenvironment. Cell Host Microbe, 14, 207-215.

[23]   Zeller, G., Tap, J., Voigt, A.Y., Sunagawa, S., Kultima, J.R., Costea, P.I., Amiot, A., Bohm, J., Brunetti, F., Habermann, N., Hercog, R., Koch, M., Luciani, A., Mende, D.R., Schneider, M.A., Schrotz-King, P., Tournigand, C., Tran Van Nhieu, J., Yamada, T., Zimmermann, J., Benes, V., Kloor, M., Ulrich, C.M., von Knebel Doeberitz, M., Sobhani, I. and Bork, P. (2014) Potential of Fecal Microbiota for Early-Stage Detection of Colorectal Cancer. Molecular Systems Biology, 10, 766.

[24]   Zackular, J.P., Rogers, M.A., Ruffin IV, M.T. and Schloss, P.D. (2014) The Human Gut Microbiome as a Screening Tool for Colorectal Cancer. Cancer Prevention Research, 7, 1112-1121.

[25]   Baxter, N.T., Ruffin IV, M.T., Rogers, M.A. and Schloss, P.D. (2016) Microbiota-Based Model Improves the Sensitivity of Fecal Immunochemical Test for Detecting Colonic Lesions. Genome Medicine, 8, 37.

[26]   Yu, J., Feng, Q., Wong, S.H., Zhang, D., Liang, Q.Y., Qin, Y., Tang, L., Zhao, H., Stenvang, J., Li, Y., Wang, X., Xu, X., Chen, N., Wu, W.K., Al-Aama, J., Nielsen, H.J., Kiilerich, P., Jensen, B.A., Yau, T.O., Lan, Z., Jia, H., Li, J., Xiao, L., Lam, T.Y., Ng, S.C., Cheng, A.S., Wong, V.W., Chan, F.K., Xu, X., Yang, H., Madsen, L., Datz, C., Tilg, H., Wang, J., Brünner, N., Kristiansen, K., Arumugam, M., Sung, J.J. and Wang, J. (2017) Metagenomic Analysis of Faecal Microbiome as a Tool towards Targeted Non-Invasive Biomarkers for Colorectal Cancer. Gut, 66, 70-78.

[27]   Bolstad, A.I., Jensen, H.B. and Bakken, V. (1996) Taxonomy, Biology, and Periodontal Aspects of Fusobacterium nucleatum. Clinical Microbiology Reviews, 9, 55-71.

[28]   Panic, N., Leoncini, E., de Belvis, G., Ricciardi, W. and Boccia, S. (2013) Evaluation of the Endorsement of the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) Statement on the Quality of Published Systematic Review and Meta-Analyses. PLoS ONE, 8, e83138.

[29]   Lijmer, J.G., Mol, B.W., Heisterkamp, S., Bonsel, G.J., Prins, M.H., van der Meulen, J.H. and Bossuyt, P.M. (1999) Empirical Evidence of Design-Related Bias in Studies of Diagnostic Tests. Journal of the American Medical Association, 282, 1061-1066.

[30]   Ahn, J., Sinha, R., Pei, Z., Dominianni, C., Wu, J., Shi, J., Goedert, J.J., Hayes, R.B. and Yang, L. (2013) Human Gut Microbiome and Risk for Colorectal Cancer. Journal of the National Cancer Institute, 105, 1907-1911.

[31]   Fukugaiti, M.H., Ignacio, A., Fernandes, M.R., Ribeiro Jr., U., Nakano, V. and Avila-Campos, M.J. (2015) High Occurrence of Fusobacterium nucleatum and Clostridium difficile in the Intestinal Microbiota of Colorectal Carcinoma Patients. Brazilian Journal of Microbiology, 46, 1135-1140.

[32]   Vogtmann, E., Hua, X., Zeller, G., Sunagawa, S., Voigt, A.Y., Hercog, R., Goedert, J.J., Shi, J., Bork, P. and Sinha, R. (2016) Colorectal Cancer and the Human Gut Microbiome: Reproducibility with Whole-Genome Shotgun Sequencing. PLoS ONE, 11, e0155362.

[33]   Li, Y.Y., Ge, Q.X., Cao, J., Zhou, Y.J., Du, Y.L., Shen, B., Wan, Y.J. and Nie, Y.Q. (2016) Association of Fusobacterium nucleatum Infection with Colorectal Cancer in Chinese Patients. World Journal of Gastroenterology, 22, 3227-3233.

[34]   Amitay, E.L., Werner, S., Vital, M., Pieper, D.H., Hofler, D., Gierse, I.J., Butt, J., Balavarca, Y., Cuk, K. and Brenner, H. (2017) Fusobacterium and Colorectal Cancer: Causal Factor or Passenger? Results from a Large Colorectal Cancer Screening Study. Carcinogenesis, 38, 781-788.

[35]   Eklof, V., Lofgren-Burstrom, A., Zingmark, C., Edin, S., Larsson, P., Karling, P, Alexeyev, O., Rutegard, J., Wikberg, M.L. and Palmqvist, R. (2017) Cancer-Associated Fecal Microbial Markers in Colorectal Cancer Detection. Int J Cancer., 141, 2528-2536.

[36]   Barukcic, I. (2018) Epstein Barr Virus: The Cause of Hodgkin’s Lymphoma. Journal of Biosciences and Medicines, 6, 75-100.

[37]   Barukcic, I. (1989) Die Kausalitat. Wissenschaftsverlag, Hamburg, 218.

[38]   Barukcic, I. (1997) Die Kausalitat. Scientia, Wilhelmshaven, 374.

[39]   Barukcic, I. (2005) Causality. New Statistical Methods. Books on Demand, Hamburg-Norderstedt, 488.

[40]   Barukcic, I. (2006) Causality. New Statistical Methods, 2nd English Edition, Books on Demand, Hamburg-Norderstedt, 488.

[41]   Barukcic, I. (2006) New Method for Calculating Causal Relationships. Proceeding of XXIIIrd International Biometric Conference, 16-21 July 2006, McGill University, Montréal, Québec, Canada, 49.

[42]   Barukcic, I. (2011) Causality I. A Theory of Energy, Time and Space. Lulu, Morrisville, 648.

[43]   Barukcic, I. (2011) Causality II. A Theory of Energy, Time and Space. Lulu, Morrisville, 376.

[44]   Barukcic, I. (2012) The Deterministic Relationship between Cause and Effect. International Biometric Conference, 26-31 August 2012, Kobe, Japan.

[45]   Barukcic, I. (2016) The Mathematical Formula of the Causal Relationship k. International Journal of Applied Physics and Mathematics, 6, 45-65.

[46]   Barukcic, K. and Barukcic, I. (2016) Epstein Barr Virus: The Cause of Multiple Sclerosis. Journal of Applied Mathematics and Physics, 4, 1042-1053.

[47]   Barukcic, I. (2016) Unified Field Theory. Journal of Applied Mathematics and Physics, 4, 1379-1438.

[48]   Barukcic, I. (2017) Helicobacter pylori: The Cause of Human Gastric Cancer. Journal of Biosciences and Medicines, 5, 1-19.

[49]   Barukcic, I. (2017) Anti Bohr: Quantum Theory and Causality. International Journal of Applied Physics and Mathematics, 7, 93-111.

[50]   Barukcic, I. (2017) Theoriae causalitatis principia mathematica. Books on Demand, Hamburg-Norderstedt, 244.

[51]   Barukcic, I. (2017) Human Papilloma Virus: A Cause of Malignant Melanoma. viXra, 10, 1-13.

[52]   Barukcic, I. (2017) Human Papillomavirus: A Cause of Human Prostate Cancer. viXra, 11, 1-57.

[53]   Barukcic, I. (2017) Human Papillomavirus: The Cause of Human Cervical Cancer. viXra, 11, 1-56.

[54]   Barukcic, I. (2017) Helicobacter pylori Is the Cause of Human Gastric Cancer. viXra, 12, 1-50.

[55]   Astorga, M.L. (2015) Diodorus Cronus and Philo of Megara: Two Accounts of the Conditional. Rupkatha Journal on Interdisciplinary Studies in Humanities, 7, 9-16.

[56]   Neyman, J. (1937) Outline of a Theory of Statistical Estimation Based on the Classical Theory of Probability. Philosophical Transactions of the Royal Society A, 236, 333-380.

[57]   Clopper, C. and Pearson, E.S. (1934) The Use of Confidence or Fiducial Limits Illustrated in the Case of the Binomial. Biometrika, 26, 404-413.

[58]   Agresti, A. and Coull, B.A. (1998) Approximate Is Better than “Exact” for Interval Estimation of Binomial Proportions. The American Statistician, 52, 119-126.

[59]   Leemis, L.M. and Trivedi, K.S. (1996) A Comparison of Approximate Interval Estimators for the Bernoulli Parameter. The American Statistician, 50, 63-68.

[60]   Louis, T.A. (1981) Confidence Intervals for a Binomial Parameter after Observing No Successes. The American Statistician, 35, 154.

[61]   Hanley, J.A. and Lippman-Hand, A. (1983) If Nothing Goes Wrong, Is Everything All Right? The Journal of the American Medical Assn., 249, 1743-1745.

[62]   Jovanovic, B.D. and Levy, P.S. (1997) A Look at the Rule of Three. The American Statistician, 51, 137-139.

[63]   Rumke, C.L. (1975) Implications of the Statement: No Side Effects Were Observed. N Engl J Med, 292, 372-373.

[64]   Fisher, R.A. (1922) On the Interpretation of X2 from Contingency Tables, and the Calculation of P. Journal of the Royal Statistical Society, 85, 87-94.

[65]   Statisitisches Bundesamt (2016) Anzahl der Todesfalle durch Ertrinken in Deutschland von 1993 bis 2016.

[66]   Statisitisches Bundesamt (2016) Sterbefalle, Lebenserwartung.

[67]   Pearson, K. (1900) X. On the Criterion That a Given System of Deviations from the Probable in the Case of a Correlated System of Variables Is Such That It Can Be Reasonably Supposed to Have Arisen from Random Sampling. The London, Edin-burgh, and Dublin Philosophical Magazine and Journal of Science, 50, 157-175.

[68]   Pearson, K. (1896) VII. Mathematical Contributions to the Theory of Evolution.-III. Regression, Heredity, and Panmixia. Philosophical Transactions of the Royal Society A, 187, 253-318.

[69]   Pearson, K. (1904) Mathematical Contributions to the Theory of Evolution. XIII. On the Theory of Contingency and Its Relation to Association and Normal Correlation. Dulau and Co., London, 1-35.

[70]   Hill, A.B. (1965) The Environment and Disease: Association or Causation? Journal of the Royal Society of Medicine, 58, 295-300.

[71]   Mackie, J. (1965) Causes and Conditions. American Philosophical Quarterly, 2, 245-264.

[72]   Kirsch, I. and Weixel, L.J. (1988) Double-Blind Versus Deceptive Administration of a Placebo. Behavioral Neuroscience, 102, 319-323.

[73]   Kirsch, I. (2000) Are Drug and Placebo Effects in Depression Additive? Biological Psychiatry, 47, 733-735.

[74]   Belot, G. (2001) The Principle of Sufficient Reason. The Journal of Philosophy, 98, 55-74.